KeyBanc analyst Matthew Gillmor upgraded Alignment Healthcare (ALHC) to Overweight from Sector Weight with a $21 price target The firm says the company is emerging as a better Medicare Advantage value-based care “mousetrap” relative to traditional models. The company’s s platform is driving consistent improvement in hospital utilization and its savings are reinvested back into member benefits, the analyst tells investors in a research note. KeyBanc believes Alignment’s model will support market share gains and above-average growth.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALHC:
- Alignment Healthcare: Strong Performance and Promising Outlook Justify Buy Rating
- Alignment Healthcare’s Earnings Call Highlights Growth and Challenges
- Barclays upgrades Alignment to Equal Weight on reduced risk
- Alignment Healthcare upgraded to Equal Weight from Underweight at Barclays
- Alignment Healthcare Reports Strong Q2 2025 Results